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 Key messages: 
 
What is already known on this subject - 
 
 Omitted medication doses can lead to increased morbidity and mortality.  
 Pharmacy assistants are unregistered members of the pharmacy workforce. 
 There is some evidence that pharmacy assistants can reduce dose omissions 
when deployed to hospital wards. 
 
 
What this study adds - 
 
 A model for pharmacy assistants to be deployed into patient-facing roles in 
secondary care as ‘medicines assistants’ 
 Preliminary evidence that pharmacy assistants can save nursing time safely 
by supporting medicines administration. 
 Further evidence that pharmacy assistants can reduce omitted doses.  
 
 
 
  
 Abstract 
Objectives: This project explored the deployment of pharmacy assistants to inpatient 
wards in a new role as ‘medicines assistants’. 
Methods: Ward-based medicines assistants (MAs) were introduced to six wards 
across two UK hospitals to support medicines administration. Each 30-bed ward 
delivered acute inpatient services with MAs supporting typical nursing medication 
administration rounds to 15 patients. Data was collected using activity diaries, 
observations, clinical audit and semi-structured interviews with pharmacy assistants, 
pharmacy technicians, clinical pharmacists, nurses, ward managers and pharmacy 
managers. Thematic analysis, descriptive statistics and the Mann Whitney U Test 
were used to analyse qualitative and quantitative data, respectively.  
Results: MAs were able to act as a point of contact between the ward and the 
pharmacy department and were perceived to save nursing time. A statistically 
significant reduction in the length of time to complete morning medication 
administration to 15-patients was observed (mean 74.5 vs. 60.8 minutes per round, 
p<0.05). On average 17.4 hours of medicines-related activity per-ward-per-week was 
carried out by MAs rather than by nursing staff. Participants identified broader 
training and clarity was needed in relation to the accountability and governance of 
patient-facing roles. 
Conclusion: Pharmacy assistants deployed as MAs can contribute to saving nursing 
time and bridge the gap between nursing and pharmacy professionals.  
 
 
 
 
 Background 
Medicines management represents a unique challenge for hospital pharmacy 
services.  Errors involving medicines remain the third largest reason for incidents in 
the United Kingdom (UK) National Health Service (NHS).1,2 Errors that result in dose 
omissions can result in death, serious harm and prolong hospital admission.3 The 
incidence of missed doses varies across the literature, ranging from 1.4% to 20%.1,4. 
Large-scale epidemiological studies, as well as smaller single site audits, report 
multiple reasons for omitted doses, with ‘patient refusal’ and ‘drug not 
available‘ being the most frequent acceptable and unacceptable reasons, 
respectively.5 Despite a move towards the use of electronic prescribing and 
medication administration systems, which are reported to reduce the frequency of 
omitted doses,4 much of the literature documents that existing strategies have shown 
limited success and present new challenges, such as vulnerability to cyber-attacks..4-
9 This evidence suggests that omitted dose rates remain problematic, with new ways 
of supporting administration needed to improve patient care.   
 
Internationally the pharmacy workforce is recognised for its involvement in medicines 
administration,10 however many organisations have yet to optimise the availability of 
the pharmacy team to deliver ward-based patient-facing activities routinely.2 . Ward-
based pharmacy services can include reviewing prescriptions, annotating orders to 
improve clarity and safety, carrying out medication-related calculations, patient 
consultations and counselling, and providing patients and staff with information that 
improves patient care.11 In the UK, these activities have typically been reserved for 
pharmacy technicians and pharmacists rather than pharmacy assistants.12 However 
the complex and lengthy nature of pharmacy technician and pharmacist training (see 
Figure 1) and associated cost may limit the availability of these personnel to 
contribute to medicines medication administration routinely or at scale.  
  
Although education, and supervision of pharmacy team members vary considerably 
across the globe,13 pharmacy assistants typically have less extensive training, are 
cheaper and easier to recruit and have a predominantly product-focused role in 
aseptic manufacturing, distribution and dispensing.14 The pharmacy assistant role 
then, may provide an alternative workforce to support medication administration.  
However, whilst pharmacy assistants may be readily recruited the majority of studies 
within the literature report findings in relation to pharmacists or pharmacy 
technicians.15 Baqir et al. suggests pharmacy assistants that were patient-facing and 
ward-based, referred to as ‘medicines assistants’ to differentiate from other 
pharmacy assistants working on wards doing product-focused tasks (e.g. topping up 
stock), can significantly reduce unacceptable omitted doses of prescribed inpatient 
medications.16 However that study did not report how MAs fitted in within existing 
ward-based teams of nurses, healthcare assistants, pharmacists and technicians or 
the broader day-to-day activities and experiences of the new role at ward-level.  
 
Aim 
The aim of this study was to implement and explore the role of MAs working on 
hospital wards in the UK. The primary objective was to examine the experiences of 
ward-based staff and MAs to identify key components of the role. The secondary 
objectives of this study were i) to explore the amount of nursing time saved by MAs;  
ii) monitor the number of patients that had more than one omitted dose of a 
prescribed medicine; and iii) monitor the number of patients that had more than one 
omitted dose of a critical medicine, prior to and following their deployment into ward-
based teams. 
 Methods 
Current service provision 
Six wards were identified across two hospitals and matched for their patient turnover 
and clinical speciality. Each ward used paper-based prescribing and had a ‘standard 
pharmacy service’, which consisted of a visit each day by a pharmacy technician and 
pharmacist to review new patients and resolve queries. The pharmacist and 
pharmacy technician would be responsible for visiting multiple wards and would 
spend, on average, two hours per day on each ward. Members of nursing staff used 
a single-check procedure to administer oral and inhaled doses and a double-check 
procedure to administer controlled drugs or medicines via other routes. Medication 
administration ‘rounds’ took place in the morning, midday, afternoon and evening. 
Nurses administered medication to small groups of patients on the ward as per 
conventional practice (e.g. one nurse administers medication to patients in Bed 1 to 
15 and another nurse administers medications to patients in Bed 16 – 30). Medicines 
were supplied to wards as original packs labelled for discharge (i.e. with a patient’s 
name and instructions for use) when pharmacy staff ordered them or as ward stock 
when ordered by nursing staff.   
 
Description of the new service 
Eight conventional pharmacy assistants were recruited in June 2016 and timetabled 
to work 7:30am until 3:30pm, with a thirty-minute lunch break. The pharmacy 
assistants were advised that they would be working as ward-based medicines 
assistants in a new role. Six assistants were assigned to specific wards (three per 
site) with two assistants assigned to the dispensary (one per site). Assistants rotated 
every twelve weeks between the ward environment and the dispensary, with the 
assistant assigned to the dispensary covering MA absences, such as annual leave or 
 sickness. The assistants spent their first rotation in the dispensary under the 
supervision of pharmacy managers, enabling familiarisation with dispensing 
procedures, computer software and pharmaceutical products. Assistants were 
introduced to ward managers from July 2016, with ward-specific inductions led by 
senior nurses. Each assistant was given flexibility to test and develop the boundaries 
of their role whilst under the supervision of pharmacy and nurse managers. A 
governance structure was developed and distributed (See Figure 2) to include 
multiple members of dispensary and ward-based teams. Managers, MAs and other 
members of ward and dispensary staff held a series of meetings with wider 
organisational stakeholders to delineate a ward-based pharmacy assistant’s job 
description, modified from the conventional dispensary-based pharmacy assistant’s 
job description. MAs were directed to ‘support medication administration’ which 
included a number of different activities ranging from obtaining medicines required 
for the medication round that were not available in the medicines trolley or patients’ 
bedside medicines cabinet, obtaining water for patients to take medication with and 
optimising medicines storage in patients’ personal medication cupboards. MAs also 
prepared packaged medications (i.e. took them out of the cupboards) for nursing 
colleagues to administer unit doses and acted as an extra pair of eyes for nursing 
colleagues, for example, making sure patients had ingested the doses left by the 
nurse once the nurse had moved on to the next patient.  
 
Evaluation of the new service  
Data collection took place between June 2016 and May 2017. This study used mixed 
methods in a sequential exploratory design.17 This design collects data in distinct 
phases, building on qualitative work using quantitative methods to explore research 
questions.  Using Leech and Onwuegbuzie typology (cited in Hadi et al.18 ) this was a 
 partially-mixed sequential dominant status design (with qualitative research given 
dominant status). Data were mixed at the interpretation stage.  
 
Qualitative aspects of the study 
Qualitative research methods were chosen as appropriate to explore the perspective 
of assistants, nursing and pharmacy colleagues. This component of the study was 
underpinned by a transcendental phenomenological approach, whereby subjective 
experiences are used to understand the textural and structural components of 
reality.19 All interviews were conducted by the same interviewer (APR), an embedded 
team member conducting research across the organisation, with experience of 
qualitative research. Participants were aware that the interviewer was involved in a 
number of research projects at the organisation as well as having roles within 
external academic institutions.  
 
A purposive convenience sample was recruited to include a range of experiences 
including senior and staff nurses, healthcare assistants, ward managers, clinical 
pharmacists, pharmacy technicians and pharmacy managers, as well as the MAs 
themselves. Participants were approached face-to-face and via email and invited to 
take part in the study by the interviewer (APR).  
 
Qualitative data was collected in a number of different work places that were 
convenient to the participants and provided a quiet and private space for the 
interview. This included clinic rooms, quiet rooms, classrooms and offices. No non-
participants were present during the interviews. The majority of participants were 
female, with only one male participant. This study used semi-structured interviews 
underpinned by a transcendental phenomenological approach. Participants gave 
informed written consent. Each interview used a pilot-tested interview schedule, was 
 audio-recorded and transcribed. Identifiable information was removed from the 
transcript. Interviews lasted approximately 20-30 minutes. All transcripts were 
returned to participants as a quality control mechanism, all transcripts were approved 
without amendment.  Inductive thematic analysis was conducted by APR, KJ, and JB, 
manually to familiarise the researchers with the data and then electronically using 
NVivo Version 11. Data analysis was conducted independently and then at regular 
data meetings to cluster codes and develop themes. Theoretical data saturation was 
determined via consensus and reached after nineteen interviews, with a further four 
interviews conducted to confirm saturation had been reached. The Pharmacy 
Academic and Research Group (PARG) interrogated the data analysis at regular 
intervals. PARG includes clinical pharmacists, consultant pharmacists, postgraduate 
research students and academics. Participants were invited to offer feedback on the 
findings at two participant engagement meetings to add validity to the analysis where 
findings were presented to participants using a PowerPoint slideshow. 
 
Quantitative aspects of the study 
Findings from the qualitative interviews indicated MAs may save nursing time in 
relation to medicines administration. The hypothesis that were tested were: 
Null hypothesis: The presence of the medicines assistants does not influence 
the time taken for medication administration by nursing staff. 
Alternate hypothesis: The presence of the medicines assistants influences 
the time taken for medication administration by nursing staff. 
 
A classification for omitted doses had been developed as part of an earlier study.16 
Acceptable omitted doses were classified as cases when a non-administration code 
had been recorded indicating the patient was ‘nil by mouth’, refusing, asleep or 
another clinical reasons (e.g. low blood pressure). Unacceptable omitted doses 
 (UOD) were defined as a non-administration code not being recorded or a non-
administration code that indicated the medication was not available. Medicines were 
classified as critical based on the NPSA Rapid Response Alert (See supplementary 
information). The number of patients with more than one unacceptable omitted dose 
(≥1 UOD) and more than one unacceptable omitted dose of a critical medicine (≥1 
UODc) was routinely collected through clinical audits conducted by hospital staff as 
part of quality improvement processes. Key outcome measures included i) the 
duration of morning medicines administration rounds, ii) percentage of patients with 
more than one unacceptable omitted dose and iii) percentage of patients with more 
than one omitted dose of critical medications (e.g. anticonvulsants).This data was 
collected for a four-week period in June 2016 at the start of the project and a four-
week period in March 2017, across six wards where assistants had been deployed. 
 
Qualitative findings also indicated that MAs may save nursing time more broadly 
through ward-based activities. The research team (APR, JB, WB, WG EH, DC) had 
previous experience of developing key outcome measures and developed a process 
to collect the fourth outcome measure iv) total nursing time saved by pharmacy 
assistants per week. Data that enabled the calculation of total nursing time saved per 
week was collected using observations and activity diaries from six nurses and six 
pharmacy assistants for two four-week periods after the deployment of the MAs. 
Nurses and MAs were trained to complete the diaries together by one author to 
ensure a standard taxonomy and layout was used. MAs recorded activities and 
duration of time spent completing the activity. Nurses validated the diaries, 
confirming that they or nursing colleagues would otherwise have completed activities 
now being completed by MAs.  
 
 Quantitative analysis was conducted using SPSS Version 22 (IBM Corp, Armonk, NY, 
USA) by a statistician (WG). Descriptive statistics and the Mann-Whitney U test was 
used to explore differences in outcome measures. Quantitative data was integrated 
with qualitative data following analysis, to enable complementary inferences to be 
made.  
 
The study received approval from Durham University School of Applied Social 
Sciences research ethics sub-committee (no identification number was issued) and 
the Northumbria Healthcare NHS Foundation Trust Research and Development 
Department. NHS REC approval was not required for this study.  
Results 
Twenty-three qualitative interviews were conducted with eight medicines assistants, 
nine nurses, (including two sisters and one charge nurse, three nurse ward 
managers, three staff nurses,) two pharmacy managers, two registered pharmacists 
and two pharmacy technicians. Interviews lasted between 20 – 30 minutes. Four 
major themes were identified and are outlined below, these are i) saving time, ii) 
accountability, iii) identity and iv) training and development. Quotes are presented as 
supplementary material.  
 
Saving time 
Participants reported saving time supporting patients to take their medications and 
this freed up nurses to take on direct care activities (Quote 1 & Quote 2).   Reviewing 
current supply levels of medicines saved nursing time and ensured continuity of 
supply (Quote 3). It was acknowledged that whilst some aspects of stock 
management would be carried out as part of routine nursing activities, Mas were able 
 to complete additional stock management tasks that are typically delayed or readily 
deferred (Quote 4). Participants described MAs as able to relieve pressures placed 
on nurses to manage medicines at ward level, and this was perceived to improve 
capacity to deal with more pertinent nursing priorities (Quote 5). 
  
Accountability issues 
The role was limited by the lack of accountability MAs had to perform particular tasks 
(Quote 6).  Whilst there was a desire for MAs to be able to do more, concerns 
regarding governance and supervision were raised by some participants (Quote 7 & 
8). There were also concerns about the accountability of MAs whilst supporting the 
medication round for particular pharmaceutical formulations that had legal or clinical 
complexity, e.g. controlled drug medication, intravenous medication and nasogastric 
feeds (Quote 9). 
  
Identity  
The perceived identity of the MAs as a ‘pharmacy person’ appeared to limit the role. 
MAs themselves described a juxtaposed identity between a pharmacy role and a 
nursing role, as being difficult to deal with (Quote 10 & 11).  However this special 
identity enhanced the role of the MAs when working in the dispensary, enabling them 
to use knowledge from the ward to improve patients’ pharmaceutical care (Quote 12). 
In one particular case, the pharmacy identity of the MA led to animosity between 
themselves and a nurse (Quote 13). Other participants felt that there were clear 
boundaries between their own nursing role and that of the MA, with the registered 
status of these participants preventing any job security concerns from the 
unregistered MAs (Quote 14 &15). 
  
 Training and development 
Integration with the ward team appeared to translate into enthusiasm for taking on 
additional nursing activities, in this case moving patients (Quote 16). Assistants 
reported that differences between the ward-based and dispensary-based roles 
developed increased empathy with patients (Quote 17). Additional training to develop 
the role was identified (Quote 18) although ‘the on the job training’ provided by the 
nursing team was acceptable (Quote 19). The majority of the participants were 
supportive of the further development of the MA role (Quote 20).  
 
Key outcome measures 
Key outcome measures included i) the duration of morning medicines administration 
rounds to 15-patients, ii) percentage of patients with more than one unacceptable 
omitted dose, iii) percentage of patients with more than one unacceptable omitted 
dose of critical medications and iv) total nursing time saved by pharmacy assistants 
per week. 
Table 1  
Supporting morning medication administration ward rounds to 15-patients reduced 
the time taken from a mean average of 74.5 minutes to 60.8 minutes. Data was 
collected from 124 administration rounds (62 standard practice, 62 with pharmacy 
assistant support). Over the investigational period, pharmacy assistants spent 63 
hours and 28 minutes supporting medicines administration rounds directly.  The data 
was non-normally distributed and therefore a non-parametric test was used to 
establish statistical significance. The Mann-Whitney U test was used and showed the 
difference between the data was statistically significant (p value 0.002). Standard 
deviation from the average increased after the assistants began supporting the 
administration rounds. This suggests that at some sites, administration rounds were 
 not reduced – this supports qualitative data reporting animosity between a nurse and 
an MA that prevented the MA being involved in administration rounds.   
 
Aggregated data collected for four weeks in June 2016 prior to the deployment of the 
MAs to wards and in March 2017 following the deployment of the MAs to wards was 
collected through exiting clinical audit practices included data for 123 patients and 
113 patients, respectively. The number of patients with more than one unacceptable 
omitted doses reduced from 22% (n = 27) to 10% (n = 12)  and the number of 
patients with more than one unacceptable omitted doses of critical medicines 
reduced from 2% (n = 3) to 0% (n = 0) following the introduction of the assistants. 
There was not sufficient data to test for statistical difference. 
 
The time spent conducting medicines-related activities by the assistants ranged from 
8.4 to 28.4 hours per week. This varied between individual assistants.  A mean 
average of 17.4 hours of medicines-related activity per week was recorded as being 
carried out by the MAs that would have previously been undertaken by members of 
the nursing team - including staff grade nurses, sisters/charge nurses and ward 
managers. The recorded activity of the assistants indicates that the additional actions 
found in the qualitative data (such as getting patient’s cups of water to take their 
medication) were not recorded in the activity diaries. These additional activities are 
likely to make up the discrepancy between a full-time position (contracted as 37.5 
hours per week) and the recorded average, however further work is needed to 
support these findings.   
 
Discussion 
 The findings demonstrate that the role of pharmacy assistants deployed as 
medicines assistants can be varied, can contribute to saving nurses time and 
highlights an opportunity for unregistered members of the pharmacy team to support 
patient-facing activities in secondary care organisations. Boundaries of the role were 
demarcated by perceptions of identity, accountability and training and development.  
The amount of time was released to nursing staff was experienced as significant 
however there were views amongst participants that this role could go further to 
release more time, if appropriate training and governance was put in place. Of 
particular pertinence was the limited training available for staff working in this patient-
facing capacity, as opposed to product-focused roles.  
 
This study supports existing work that demonstrates a reduction in medication 
administration omissions when MAs assist nurse-led administraiton.16 Although a 
pilot trial reported by Keers et al. revealed only a small impact on the average 
number of omitted doses when pharmacy technicians supported administration,15 our 
study suggests that this outcome may also be achieved with MAs. A comparative 
study is needed to observe if MAs may be better placed to support medicines 
administration than pharmacy technicians. This work justifies critical reflection by 
policy makers on the most appropriate member of the team to perform medication 
administration support services, which varies considerably across the globe.10  
 
The knowledge base is pushed further by this study as it provides an account of the 
capability of MAs to contribute to patient facing ward services at a time when the 
nursing workforce is under unprecedented pressure.  The direction of travel for the 
hospital workforce appears to focus on extending roles for unregistered professionals, 
for example physicians’ associates and nursing assistants.10,20-22 The role of the 
assistant within this project has improved nursing experiences and saved time. This 
work therefore brings much needed attention to, and provides evidence of, the 
 opportunities to develop unregistered members of the pharmacy team. The relative 
ease of recruitment and training of these staff may provide significant opportunity to 
help address some of the immediate challenges within the wider healthcare 
workforce and health service delivery.   
  
Limitations of the study 
It is likely that this work is not sufficient to generalise the findings broadly however 
insights can be gained and considered in similar settings and contexts. Data must be 
interpreted carefully however, as the majority of once daily medications are typically 
administered as part of the morning round and so the reduction in the duration of the 
medication administration round may be less substantial at other times, such as 
midday, afternoon and evening.  Additionally, whilst nurses validated the MAs activity 
diaries to calculate the amount of nursing time saved on medicines related activities, 
this was a subjective measure – future studies should look to more objective 
quantitative measurements to build on these findings and also incorporate all 
activities where time is saved and not just those specifically medicines related using 
a time and space study. Further work is also required to understand the influence 
pharmacy assistants working at ward level as MAs may have had on nursing job 
satisfaction, stress levels and recruitment more broadly in the long term.  
Conclusions 
Pharmacy assistants are able to adopt the role of medicines assistants and use their 
experiences of product-focused activities, such as dispensing, to deliver patient-
facing services and support nursing and pharmacy professionals in acute hospital 
settings at ward-level. 
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 Table 1 Key outcome measures 
 Mean SD 
Duration of morning medicine administration round (mins)   
  Standard practice  74.5 9.0 
  With pharmacy assistant support  60.8 17.5 
  Time saved  13.7 19.6 
Time saved per activity per week (hrs) 
How many times an activity was recorded each week  
  
  Obtaining supply of temporary stock items  
 
0.7 
10.3 
0.5 
11.3 
  Obtaining supply from stock cupboard 
 
0.9 
15 
0.9 
8.1 
  Obtaining supply of pre-labelled products 
 
0.5 
6.3 
0.5 
6.4 
  Supporting medication administration  
 
4.1 
22.8 
5.4 
32.9 
  Visiting the dispensary to obtain medication 
 
1.5 
6.2 
1.3 
4.3 
  Supporting the supply of medicines for use post-discharge 
 
4.4 
7.8 
4.9 
8.1 
  Preparing products need for intravenous administration 
 
1.2 
14.0 
1.2 
14.3 
  Unpacking delivery 
 
0.9 
1.7 
0.4 
1.5 
  Tidying the treatment room 
 
0.7 
1.7 
0.4 
1.5 
  Waste management 
 
0.4 
1.3 
0.2 
0.75 
  Acting as a point of contact for pharmacy on the ward 
 
1.1 
1.3 
0.9 
0.75 
  Ordering pharmacy products to be held as stock on the ward 
 
1.0 
1.0 
0.0 
0.0 
Total time saved per week 17.4 9.517 
Point prevalence quality measures     
  
Per cent of patients with more than one unacceptable omitted dose 
baseline  (June-16) (n = 123) 
 
22%  
(n = 27) 
0.1 
  
Per cent of patients with more than one unacceptable omitted dose 
after deployment of Medicines Assistants (Mar-17) (n=113) 
 
10% 
(n = 12) 
0.1 
  
Per cent of patients with more than one unacceptable omitted dose of a 
critical medicine baseline (June-16) (n = 123)_ 
 
2% 
(n = 3) 
0.0 
  
Per cent of patients with more than one unacceptable omitted dose of a 
critical medicine after deployment of Medicines Assistants (Mar-17) 
(n=113) 
 
0% 
(n = 0) 
0.0 
      
  
References  
1.  Elliott R, Camacho E, Campbell F, et al. Rapid evidence synthesis and 
economic analysis of the prevalence and burden of medication error in the 
UK. . Prevalence and Economic Burden of Medication Errors in The NHS in 
England Policy Research Unit in Economic Evaluation of Health and Care 
Interventions University of Sheffield, University of York, University of 
Manchester, 2018. 
2.  National Patient Safety Agency (NPSA) Safe Medication Practice Team. 
Safety in doses: improving the use of medicines in the NHS. London: NPSA, 
2007. 
3.  National Patient Safety Agency (NPSA). Rapid Response Report 
NPSA/2010/RRR009: Reducing Harm from Omitted and Delayed Medicines 
in Hospital. London: NPSA, 2010. 
4.  McLeod MC, Barber N, Franklin BD. Methodological variations and their 
effects on reported medication administration error rates. BMJ Qual Saf 
2013;22(4):278-89. doi: 10.1136/bmjqs-2012-001330 [published Online First: 
2013/01/17] 
5.  Coleman JJ, Hodson J, Brooks HL, et al. Missed medication doses in 
hospitalised patients: a descriptive account of quality improvement measures 
and time series analysis. International Journal for Quality in Health Care 
2013;25(5):564-72. doi: 10.1093/intqhc/mzt044 
6.  Green E, Griffiths FH, F., Wyatt S. Desperately Seeking Certainty: Bone 
Densitometry, the Internet and Health Care Contexts. Hampshire: Palgrave 
Macmillan 2006. 
 7.  Nettleman MD, Bock MJ. The epidemiology of missed medication doses in 
hospitalized patients. Clin Perform Qual Health Care 1996;4(3):148-53. 
[published Online First: 1996/06/06] 
8.  Ridge KW, Jenkins DB, Noyce PR, et al. Medication errors during hospital 
drug rounds. Qual Health Care 1995;4(4):240-3. 
9.  Nagar S, Davey N. Reducing avoidable time delays in immediate medication 
administration - learning from a failed intervention. BMJ Quality Improvement 
Reports 2015;4(1) doi: 10.1136/bmjquality.u206468.w2612 
10.  Hawthorne N, Anderson C. The global pharmacy workforce: a systematic 
review of the literature. Human Resources for Health 2009;7(48) 
11.  Onatade, Miller, Sanghera. A quantitative comparison of ward-based clinical 
pharmacy activities in 7 acute UK Hospitals. Int J Clin Pharm 2016 
12.  The General Pharmaceutical Council. Pharmacy technician education and 
training: The General Pharmaceutical Council; 2017 [Available from: 
https://www.pharmacyregulation.org/education/pharmacy-technician 
accessed 22nd October 2017. 
13.  Koehler T, Brown A. A global picture of pharmacy technician and other 
pharmacy support workforce cadres. Res Social Adm Pharm 2017;13(2):271-
79. doi: 10.1016/j.sapharm.2016.12.004 [published Online First: 2017/02/14] 
14.  Health Education England. Pharmacy assistant: Health Education England,; 
2017 [Available from: https://www.healthcareers.nhs.uk/explore-
roles/pharmacy/roles-pharmacy/pharmacy-assistant accessed 23 October 
2017. 
15.  Keers R, Seston E, Kontopantelis E, et al. Pharmacy TECHnician supported 
MEDication administration rounds (TECHMED) - Final Project Report. 
Manchester: University of Manchester, 2017. 
 16.  Baqir W, Jones K, Horsley W, et al. Reducing unacceptable missed doses: 
pharmacy assistant-supported medicine administration. Int J Pharm Pract 
2015;23(5):327-32. 
17.  Wimpenny P, Kirkpatrick P. Roles and systems for routine medication 
administration to prevent medication errors in hospital-based, acute care 
settings: a systematic review. International Journal of Evidence-based 
Healthcare 2010;8(3):200. 
18.  Hadi MA, Alldred DP, Closs SJ, et al. Mixed-methods research in pharmacy 
practice: recommendations for quality reporting (part 2). International Journal 
of Pharmacy Practice 2014;22:99-100. 
19.  Moustakas C. Phenomenological Research Methods. London: Sage 
Publications Ltd. 1994. 
20.  Marchant R. The Scope of Medical Regulation: Physicians' Associates 
London: General Medical Council 2015. 
21.  Frenk J, Chen L, Bhutta ZA, et al. Health professionals for a new century: 
transforming education to strengthen health systems in an interdependent 
world. The Lancet 2010;376(9756):1923-58. doi: 10.1016/S0140-
6736(10)61854-5 
22.  World Health Organization. Global Strategy for Human Resources for Health: 
Workforce 2030. Geneva: World Health Organization, 2016. 
 
